OCT imaging to evaluate stent for treating coronary artery bifurcation lesions

Tryton Medical (Durham, NC), which develops stents for treating coronary artery bifurcation lesions, will begin a clinical trial using the company's Tryton Side Branch Stent, with evaluation by intravascular optical coherence tomography (OCT) imaging technology. The Nordic-Baltic Dedicated Bifurcation Trial, which will involve 150 patients, will examine the role of final kissing balloon inflations in patient outcomes.

Related: Totally tubular: Cardiovascular OCT goes prime time

The trial is the latest investigation from the Study Group, which has a history of examining different techniques for treating bifurcation lesions in the Nordic I, II, III, and IV studies. The publications associated with these studies are among the most frequently cited by interventional cardiologists.

The Tryton Side Branch Stent is supported by clinical evidence in more than 1,000 patients. Published data in a patient pooled analysis from more than 900 patients treated with the Tryton Side Branch Stent in more than eight European post-marketing registries demonstrated low target lesion revascularization rates of 2.9 percent at six months and 4.0 percent at one year, and a low 0.5 percent thrombosis rate at one year. More than 7,500 patients have been treated with the stent, which is available commercially throughout Europe, Russia, and the Middle East.

The company has completed enrollment in the first and only randomized controlled U.S. IDE pivotal clinical trial evaluating a dedicated bifurcation stent, and anticipates study outcomes will be presented at the Transcatheter Cardiovascular Therapeutics 2013 (TCT 2013) conference, to take place October 27 through November 1, 2013, in San Francisco, CA.


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

Optical brain imaging noninvasively measures small perfusion changes caused by visual stimulation

An optical brain imaging system can track very small, focal changes in cortical perfusion resulting from visual stimulation.

Optical Coherence Tomography: Beyond better clinical care: OCT's economic impact

The optical coherence tomography (OCT) industry has grown dramatically in its first 25 years.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World